About
Kidney Disease Treatment
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
188
By Phase
PHASE3: 2PHASE2: 1PHASE1/PHASE2: 2PHASE2/PHASE3: 2
By Status
COMPLETED: 6TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT03938272Lead Sponsor
An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
PHASE3Terminated
22 participants
Started: Mar 14, 2019 · Completed: Jul 14, 2021
NCT03116685Lead Sponsor
A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
PHASE3Completed
25 participants
Started: Jan 9, 2018 · Completed: Apr 15, 2021
NCT02000219Lead Sponsor
Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis
PHASE2Completed
12 participants
Started: May 19, 2014 · Completed: Jan 29, 2020
NCT02012985Lead Sponsor
Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria
PHASE1/PHASE2Completed
28 participants
Started: Dec 31, 2013 · Completed: Jan 31, 2015
NCT01127087Collaborator
Oxazyme in Patients With Hyperoxaluria
PHASE1/PHASE2Completed
22 participants
Started: May 31, 2010 · Completed: Oct 31, 2011
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...